1. Home
  2. LMAT vs ADMA Comparison

LMAT vs ADMA Comparison

Compare LMAT & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$94.30

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$8.66

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMAT
ADMA
Founded
1983
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
2006
2012

Fundamental Metrics

Financial Performance
Metric
LMAT
ADMA
Price
$94.30
$8.66
Analyst Decision
Buy
Strong Buy
Analyst Count
5
4
Target Price
$105.80
$25.67
AVG Volume (30 Days)
292.9K
3.3M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
0.93%
N/A
EPS Growth
30.57
N/A
EPS
0.68
0.19
Revenue
$249,602,000.00
$42,219,783.00
Revenue This Year
$14.21
$27.46
Revenue Next Year
$8.88
$22.11
P/E Ratio
$138.13
$45.89
Revenue Growth
13.53
43.85
52 Week Low
$79.01
$7.21
52 Week High
$118.01
$20.46

Technical Indicators

Market Signals
Indicator
LMAT
ADMA
Relative Strength Index (RSI) 47.80 52.30
Support Level $82.26 $7.38
Resistance Level $97.83 $8.90
Average True Range (ATR) 3.02 0.33
MACD 0.63 0.12
Stochastic Oscillator 61.26 67.24

Price Performance

Historical Comparison
LMAT
ADMA

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: